Literature DB >> 20169330

[Treatment of primary varicosis].

T Noppeney1, H Nüllen.   

Abstract

While the treatment of varicose veins has remained unchanged over the past 100 years based on the three principles of compression, sclerotherapy, and classic varicose vein surgery, alternative approaches and advancements in treatment have developed in the last 10 years such as foam sclerotherapy, endovenous laser therapy, and radiofrequency obliteration. In contrast to classic varicose vein surgery, prospective, randomized, comparative studies are available with respect to the modern treatment procedures. They clearly show that endovenous thermal techniques are not inferior to the classic operation regarding the perioperative complication rate. There appears to be a tendency toward considerably fewer perioperative complaints with endovenous laser therapy and in particular with radiofrequency obliteration. Foam sclerotherapy represents a minimally invasive alternative that is markedly cost-effective. Even though the occlusion rate of the root veins after foam sclerotherapy is not as good as after endovenous therapy, the method is initially very effective. Especially in cases of recurrent varicose veins from the saphenofemoral or popliteal junction, foam sclerotherapy should be considered as the ideal method. All procedures significantly improve the patients' quality of life and the symptom complaints related to varicose veins. They are not in competition, but rather partially complement each other so that a combination of several approaches is quite judicious.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169330     DOI: 10.1007/s00108-009-2515-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  18 in total

1.  Unresectable liver metastases.

Authors:  Josef E Fischer
Journal:  J Am Coll Surg       Date:  2002-09       Impact factor: 6.113

Review 2.  European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.

Authors:  Franz-Xaver Breu; Stephan Guggenbichler
Journal:  Dermatol Surg       Date:  2004-05       Impact factor: 3.398

3.  Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance.

Authors:  K A Myers; D Jolley; A Clough; J Kirwan
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-10-24       Impact factor: 7.069

Review 4.  Endovenous therapies of lower extremity varicosities: a meta-analysis.

Authors:  Renate van den Bos; Lidia Arends; Michael Kockaert; Martino Neumann; Tamar Nijsten
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

5.  Endovenous laser treatment: a morphological study in an animal model.

Authors:  M Vuylsteke; J Van Dorpe; J Roelens; T De Bo; S Mordon
Journal:  Phlebology       Date:  2009-08       Impact factor: 1.740

6.  Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein.

Authors:  R Fischer; N Linde; C Duff; C Jeanneret; J G Chandler; P Seeber
Journal:  J Vasc Surg       Date:  2001-08       Impact factor: 4.268

7.  The effect of long saphenous vein stripping on quality of life.

Authors:  R K MacKenzie; A Paisley; P L Allan; A J Lee; C V Ruckley; A W Bradbury
Journal:  J Vasc Surg       Date:  2002-06       Impact factor: 4.268

8.  Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up.

Authors:  F Lurie; D Creton; B Eklof; L S Kabnick; R L Kistner; O Pichot; C Sessa; S Schuller-Petrovic
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-01       Impact factor: 7.069

9.  Durability of reflux-elimination by a minimal invasive CHIVA procedure on patients with varicose veins. A 3-year prospective case study.

Authors:  J M Escribano; J Juan; R Bofill; J Maeso; A Rodríguez-Mori; M Matas
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-02       Impact factor: 7.069

10.  Saphenous vein sparing surgery: principles, techniques and results.

Authors:  P Zamboni; M G Marcellino; M Cappelli; C V Feo; V Bresadola; G Vasquez; A Liboni
Journal:  J Cardiovasc Surg (Torino)       Date:  1998-04       Impact factor: 1.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.